LogoLogoLogoLogo
  • Home
  • Ming Hsieh
  • The Institute
  • Research
  • Investigators
  • Funding
✕
Next Generation CD19 CAR-T for the treatment of lymphoid malignancies
July 11, 2018
Chimeric Antigen Receptor Engineered Natural Killer Cells as a Carrier of Drug-Encapsulated Nanoparticles Targeting Adenosine Receptors in Ovarian Cancer
July 11, 2018

Characterizing the immune microenvironment of lymphoma and myeloma using multiplexed imaging mass cytometry

insert text

Menu

  • Home
  • Ming Hsieh
  • The Institute
  • Research
  • Investigators
  • Funding

© The Ming Hsieh Institute | vprsch@usc.edu

Website issues? Contact USC Provost IT